高级检索
当前位置: 首页 > 详情页

Prognostic significance of systemic immunoinflammatory biomarkers in patients with clear cell renal cell carcinoma: a retrospective multicenter analysis

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]First Peoples Hosp Yunnan Prov, Dept Urol, Kunming, Peoples R China [2]Kunming Univ Sci & Technol, Affiliated Hosp, Dept Urol, Kunming, Peoples R China
出处:
ISSN:

关键词: ccRCC ISUP NLR PLR LMR SII SIRI

摘要:
Aims This study aims to investigate the associations between blood laboratory findings, systemic immune-inflammatory factors, ISUP grade, and prognostic outcomes in patients diagnosed with clear cell renal cell carcinoma (ccRCC).Methods Data were collected from patients diagnosed with ccRCC at the First People's Hospital of Yunnan Province and Xiangya Hospital of Central South University between 2010 and 2022, encompassing pertinent pathological and clinical information. We employed ordered logistic regression analysis to establish the ISUP grading model and conducted association analyses to explore the relationship between ISUP classification and the 2-year survival rate.Results A total of 1,635 patients were included in the study. Our findings indicate that ISUP grading is significantly correlated with serum albumin levels, blood chloride concentrations, the platelet-to-lymphocyte ratio (PLR), and the systemic inflammation response index (SIRI). The preoperative 2-year survival model demonstrated associations with platelet counts (PLT), albumin levels, blood chloride concentrations, and PLR, AUC (0.776 95%IC 0.710, 0.843). Furthermore, the postoperative 2-year survival model exhibited robust correlations with PLT, albumin levels, blood chloride concentrations, PLR, and ISUP grade, AUC (0.877, 95%IC 0.825, 0.917).Conclusion This study demonstrated the relationship between systemic immune markers, ISUP classification, and prognosis. It established preoperative models for predicting ISUP classification, as well as models for predicting 2-year survival rates both preoperatively and postoperatively.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2025]版:
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 免疫学
JCR分区:
出版当年[2024]版:
Q1 IMMUNOLOGY
最新[2024]版:
Q1 IMMUNOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]First Peoples Hosp Yunnan Prov, Dept Urol, Kunming, Peoples R China [2]Kunming Univ Sci & Technol, Affiliated Hosp, Dept Urol, Kunming, Peoples R China
通讯作者:
通讯机构: [1]First Peoples Hosp Yunnan Prov, Dept Urol, Kunming, Peoples R China [2]Kunming Univ Sci & Technol, Affiliated Hosp, Dept Urol, Kunming, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:98295 今日访问量:0 总访问量:858 更新日期:2025-10-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号 ICP备案:滇ICP备15003244号